Category: Access campaign
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Secrets Cost Lives: Transparency and access to medical products
Deepak Shegar: Battling DR-TB with resilience and dreams
MSF reveals cost of its landmark TB clinical trial: €34 million
As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination
Namrata’s journey: triumph over drug-resistant Tuberculosis
Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis
MSF response to signing of EFTA-India trade agreement
